Downregulation of TCF19 and ATAD2 causes endothelial cell cycle arrest at the transition from cardiac hypertrophy to heart failure
Basic Research in Cardiology · 2025
DOI: 10.1007/s00395-025-01139-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, 2025. Verfasst von Elias Erny und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104, Freiburg, Germ…. Hauptthemen laut MEDLINE: Cardiomegaly, DNA-Binding Proteins, Heart Failure, Cell Cycle Checkpoints. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung zur Förderung der Erforschung der Zivilisationserkrankungen, Universitätsklinikum Freiburg.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Cardiac hypertrophy is a key mechanism that allows the heart to adapt to increased load, but in the long term is associated with a higher risk for heart failure, arrhythmia, and death. During hypertrophic growth, cardiac myocytes signal to endothelial cells via vascular endothelial growth factor (VEGF) to promote angiogenesis and maintain myocardial oxygen supply. Insufficient angiogenesis leads to a decline in capillary density and drives the progression from compensated cardiac hypertrophy to heart failure. Here, we studied the time course of endothelial cell gene expression during heart failure development and identified transcriptional regulators of cell proliferation and angiogenesis. We applied transverse aortic constriction (TAC) in mice and isolated cardiac endothelial cells for RNA sequencing after 6 h and 1, 3, 7, or 28 days to create an inventory of gene expression during the course of cardiac hypertrophy and failure. Echocardiography revealed that decompensated heart failure occurred between days 7 and 28 after TAC. At the same time, we observed a switch in endothelial cell gene expression with an upregulation of proliferation markers in the hypertrophy state but downregulation in decompensated heart failure. Of note, endothelial cell cycle arrest occurred despite strong VEGF signaling from cardiac myocytes, indicating VEGF resistance. To investigate how endothelial cell proliferation is transcriptionally regulated, we performed a weighted gene co-expression network analysis and identified a module of 180 cell cycle-related genes. We predicted transcription factor 19 (TCF19), ATPase family AAA domain containing 2 (ATAD2), and transcription factor Dp-1 (TFDP1) to be central regulators of this gene module. Knockdown of TCF19 and ATAD2 by siRNA in HUVECs led to a downregulation of the marker of proliferation MKI67 and repressed cell proliferation, tube formation, and cell migration, confirming their regulatory function. In heart tissue biopsies from patients with aortic stenosis, TCF19 and ATAD2 abundance were positively correlated with endothelial cell proliferation. TCF19 or ATAD2 control the expression of a gene network involved in endothelial cell proliferation and angiogenesis. Downregulation of TCF19 and ATAD2 is associated with endothelial cell cycle arrest and an impaired angiogenic response to VEGF signaling that may promote the transition from compensated cardiac hypertrophy to heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104, Freiburg, Germany.
- Institute of Neuropathology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
- Division of Molecular Hematology, Department of Medicine I, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
- Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
- Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104, Freiburg, Germany. achim.lother@uniklinik-freiburg.de.
- Interdisciplinary Medical Intensive Care, Faculty of Medicine, Medical Center - University of Freiburg, University of Freiburg, Freiburg, Germany. achim.lother@uniklinik-freiburg.de.
ORCID-Profile: Achim Lother
Förderung
- Stiftung zur Förderung der Erforschung der Zivilisationserkrankungen
- Universitätsklinikum Freiburg
Zitieren
APA
Erny, E., Koentges, C., Mukherjee, D., Wirth, L., Kamaras, C., Zell, F., Hossfeld, M., Groß, O., & Lother, A. (2025). Downregulation of TCF19 and ATAD2 causes endothelial cell cycle arrest at the transition from cardiac hypertrophy to heart failure. Basic Research in Cardiology. https://doi.org/10.1007/s00395-025-01139-4
Vancouver
Erny E, Koentges C, Mukherjee D, Wirth L, Kamaras C, Zell F, et al. Downregulation of TCF19 and ATAD2 causes endothelial cell cycle arrest at the transition from cardiac hypertrophy to heart failure. Basic Research in Cardiology. 2025. doi:10.1007/s00395-025-01139-4
BibTeX
@article{Erny2025,
author = {Erny, Elias and Koentges, Christoph and Mukherjee, Debanjan and Wirth, Luisa and Kamaras, Christos and Zell, Franziska and Hossfeld, Madelon and Groß, Olaf and Lother, Achim},
title = {Downregulation of TCF19 and ATAD2 causes endothelial cell cycle arrest at the transition from cardiac hypertrophy to heart failure},
journal = {Basic Research in Cardiology},
year = {2025},
doi = {10.1007/s00395-025-01139-4}
}
EUVIMED